pH‐Responsive Probiotic‐Liposome Hybrid System Synergistically Treats Radiation‐Induced Injury via Dual Mechanisms of Anti‐Inflammatory and Microbiome Modulation
Advanced Healthcare Materials · 2025
DOI: 10.1002/adhm.202501642 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Healthcare Materials, 2025. Verfasst von Heshuo Fan und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology at the First Affiliated Hospital, State Key Laboratory of Radiation Medicine and Protection, School of Radiation Medicine and…. Hauptthemen laut MEDLINE: Liposomes, Probiotics, Anti-Inflammatory Agents, Gastrointestinal Microbiome. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 45 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Key Laboratory of Radiation Damage and Treatment of Jiangsu Provincial Universities and Colleges, Suzhou Fundamental Research Project.
Abstract (Originalsprache)
Radiation‐induced intestinal injury poses significant clinical challenges in radiotherapy. This study develops an oral pH‐responsive probiotic‐liposome hybrid system (EcN PIN ‐L) by conjugating Escherichia coli Nissle 1917 (EcN) with pinocembrin (PIN)‐loaded liposomes (B‐Lip‐PIN) via biotin‐streptavidin binding and encapsulating them in Eudragit L100‐55 (L100‐55). The system resists gastric acid, releases bacteria in intestinal pH conditions, and combines PIN's anti‐inflammatory properties with EcN's probiotic effects. In irradiated mice, EcN PIN ‐L demonstrates effective intestinal colonization and multiple therapeutic benefits: it reduces pro‐inflammatory cytokines (TNF‐α, IL‐17A), enhances intestinal barrier function, and decreases epithelial apoptosis. 16S rRNA sequencing reveals improved microbiota homeostasis with increased beneficial bacteria and decreased harmful species. The system shows superior efficacy compared to individual components, addressing both inflammatory damage and microbial dysbiosis while maintaining biocompatibility. These results highlight EcN PIN ‐L as a promising dual‐mechanism therapy for radiation‐induced intestinal injury, offering targeted delivery and combined anti‐inflammatory/microbiome‐modulating action.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pathology at the First Affiliated Hospital, State Key Laboratory of Radiation Medicine and Protection, School of Radiation Medicine and Protection & School for Radiological and Interdisciplinary Sciences (…
- Department of Stomatology, Taizhou People's Hospital Affiliated to Nanjing Medical University, Taizhou, 225300, China.
- Department of Pathology, the First Affiliated Hospital of Soochow University, Suzhou, 215000, China.
ORCID-Profile: Lin Hu
Förderung
- National Natural Science Foundation of China
- Key Laboratory of Radiation Damage and Treatment of Jiangsu Provincial Universities and Colleges
- Suzhou Fundamental Research Project
- Priority Academic Program Development of Jiangsu Higher Education Institutions
Zitieren
APA
Fan, H., Li, C., Zhang, Z., Hu, M., Liu, S., Wu, A., Wang, Y., Lei, Z., Guo, L., & Hu, L. (2025). pH‐Responsive Probiotic‐Liposome Hybrid System Synergistically Treats Radiation‐Induced Injury via Dual Mechanisms of Anti‐Inflammatory and Microbiome Modulation. Advanced Healthcare Materials. https://doi.org/10.1002/adhm.202501642
Vancouver
Fan H, Li C, Zhang Z, Hu M, Liu S, Wu A, et al. pH‐Responsive Probiotic‐Liposome Hybrid System Synergistically Treats Radiation‐Induced Injury via Dual Mechanisms of Anti‐Inflammatory and Microbiome Modulation. Advanced Healthcare Materials. 2025. doi:10.1002/adhm.202501642
BibTeX
@article{Fan2025,
author = {Fan, Heshuo and Li, Chen and Zhang, Zhehao and Hu, Mengyuan and Liu, Shu and Wu, Anqing and Wang, Yuhong and Lei, Zhe and Guo, Lingchuan and Hu, Lin},
title = {pH‐Responsive Probiotic‐Liposome Hybrid System Synergistically Treats Radiation‐Induced Injury via Dual Mechanisms of Anti‐Inflammatory and Microbiome Modulation},
journal = {Advanced Healthcare Materials},
year = {2025},
doi = {10.1002/adhm.202501642}
}
EUVIMED